- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Peptide-oligourea hybrids analogue of GLP-1 with improved action in vivo ; volume:10 ; number:1 ; day:25 ; month:2 ; year:2019 ; pages:1-9 ; date:12.2019
Nature Communications ; 10, Heft 1 (25.2.2019), 1-9, 12.2019
- Creator
-
Fremaux, Juliette
Venin, Claire
Mauran, Laura
Zimmer, Robert H.
Guichard, Gilles
Goudreau, Sébastien R.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-019-08793-y
- URN
-
urn:nbn:de:101:1-2019031900243918932825
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Fremaux, Juliette
- Venin, Claire
- Mauran, Laura
- Zimmer, Robert H.
- Guichard, Gilles
- Goudreau, Sébastien R.
- SpringerLink (Online service)
Other Objects (12)
Engineering of a GLP-1 analogue peptide/anti-PCSK9 antibody fusion for type 2 diabetes treatment
Glucagon-like peptide 1 (GLP-1)
Semaglutide: Charting New Horizons in GLP-1 Analogue Outcome Studies
Correction to: Semaglutide: Charting New Horizons in GLP-1 Analogue Outcome Studies
WT1 peptide analogue WT1-126Y enhances leukemia lysis
C-Peptide Area Under the Curve at Glucagon Stimulation Test Predicts Glucose Improvements by GLP-1 Receptor Analogue: A Retrospective Observational Study
Oral GLP-1 analogue: perspectives and impact on atherosclerosis in type 2 diabetic patients
Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes
Glucagon-like peptide (GLP)-1 regulation of lipid and lipoprotein metabolism
Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor
Small peptide-based GLP-1R ligands: an approach to reduce the kidney uptake of radiolabeled GLP-1R-targeting agents?
Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications
Engineering of a GLP-1 analogue peptide/anti-PCSK9 antibody fusion for type 2 diabetes treatment
Glucagon-like peptide 1 (GLP-1)
Semaglutide: Charting New Horizons in GLP-1 Analogue Outcome Studies
Correction to: Semaglutide: Charting New Horizons in GLP-1 Analogue Outcome Studies
WT1 peptide analogue WT1-126Y enhances leukemia lysis
C-Peptide Area Under the Curve at Glucagon Stimulation Test Predicts Glucose Improvements by GLP-1 Receptor Analogue: A Retrospective Observational Study
Oral GLP-1 analogue: perspectives and impact on atherosclerosis in type 2 diabetic patients
Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes
Glucagon-like peptide (GLP)-1 regulation of lipid and lipoprotein metabolism
Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor
Small peptide-based GLP-1R ligands: an approach to reduce the kidney uptake of radiolabeled GLP-1R-targeting agents?
Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications
Engineering of a GLP-1 analogue peptide/anti-PCSK9 antibody fusion for type 2 diabetes treatment
Glucagon-like peptide 1 (GLP-1)
Semaglutide: Charting New Horizons in GLP-1 Analogue Outcome Studies
Correction to: Semaglutide: Charting New Horizons in GLP-1 Analogue Outcome Studies
WT1 peptide analogue WT1-126Y enhances leukemia lysis
C-Peptide Area Under the Curve at Glucagon Stimulation Test Predicts Glucose Improvements by GLP-1 Receptor Analogue: A Retrospective Observational Study
Oral GLP-1 analogue: perspectives and impact on atherosclerosis in type 2 diabetic patients
Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes
Glucagon-like peptide (GLP)-1 regulation of lipid and lipoprotein metabolism
Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor
Small peptide-based GLP-1R ligands: an approach to reduce the kidney uptake of radiolabeled GLP-1R-targeting agents?